Gapping down
In reaction to earnings/guidance:
- BBBY -13.3%, THTX -4.2%, LNDC -3.7%, REVG -2.6%, RGP -2%, LNN -1.7%
Other news:
- DBVT -11.3% (changes U.S. reporting status and final approval of global restructuring process)
- PLYA -7.1% (prices 35 mln shares of common stock by co and selling shareholders at $5.00 per share)
- MPW -4.8% (to acquire £800 mln in behavioral hospitals; also prices offering of 32 mln shares of common stock at $20.05 per share)
- DMTK -4.6% (prices offering of 4,237,288 shares of its common stock at $29.50 per share)
- HARP -4.5% (prices offering of 5,882,352 shares of its common stock at $17.00 per share)
- ADC -3.1% (prices offering of 3 mln shares of common stock for gross proceeds of approximately $195 mln)
- INN -3% (launches convertible notes offering)
- RGNX -2.4% (stock offering)
- BLNK -1.9% (files for 5 mln share offering; also files for mixed securities shelf offering)
- NEO -1.8% (prices offering of 4,081,632 shares of its common stock at $49.00 per share and $300 mln of 0.25% convertible senior notes due 2028)
- VNE -1.7% (updates outlook)
- AR -1.1% (prices 31.4 million shares of its common stock at $6.35/share to certain holders of its 4.25% Convertible Senior Notes due 2026)
- ARGX -1.1% (ZLAB and ARGX announce collaboration for efgartigimod in Greater China)
Analyst comments:
- MMM -1.3% (downgraded to Underperform from Neutral at BofA Securities)
- SPWH -1.1% (downgraded to Neutral from Outperform at Credit Suisse)
- WEN -0.9% (downgraded to Perform from Outperform at Oppenheimer)
- RACE -0.7% (downgraded to Neutral from Buy at Citigroup)
- KTOS -0.7% (downgraded to Hold from Buy at Jefferies)